Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, is elated about not only her company's achievements as the first Indian biotech company to get a US FDA nod for a biosimilar drug but is more happy about India and its talent making a mark in the global arena to prove naysayers ...
Read more: 'Biosimilars need huge investments, longer timelines'